Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
<p>Abstract</p> <p>Background</p> <p>Insulin resistance (IR) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease (NAFLD). Therefore, correction of IR is a relevant therapeutic target.</p> <p>We performed the current trial...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2012-06-01
|
| Serie: | Cardiovascular Diabetology |
| Accesso online: | http://www.cardiab.com/content/11/1/61 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|